Related Experiment Video
Updated: May 12, 2026

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
[Activated phosphoinositide 3-kinase delta syndrome: report of seven cases]
Qing-Hua Liu1, Li Peng1, Han Huang1
1Pediatric Medical Center, First Hospital Affiliated to Hunan Normal University/Hunan Provincial People's Hospital/Hunan Provincial Key Laboratory of Pediatric Respiratory Disease, Changsha 410005, China.
Insights
Activated phosphoinositide 3-kinase delta syndrome (APDS) in children often presents with recurrent infections and enlarged lymph nodes. Early recognition of key symptoms is crucial for timely diagnosis and management of this rare immune disorder.
Area of Science:
- Immunology
- Genetics
- Pediatrics
Background:
- Activated phosphoinositide 3-kinase delta syndrome (APDS) is a primary immunodeficiency.
- Understanding the clinical spectrum and genetic basis of APDS is essential for diagnosis.
Purpose of the Study:
- To summarize clinical data of 7 children diagnosed with APDS.
- To enhance the understanding of APDS in pediatric patients.
Main Methods:
- Retrospective analysis of clinical data from 7 APDS children.
- Data collected from January 2019 to August 2023 at Hunan Provincial People's Hospital.
Main Results:
- All 7 children experienced recurrent respiratory infections, hepatosplenomegaly, and lymphadenopathy.
- Common findings included sepsis (5/7), otitis media (3/7), and caries (3/7).
- The p.E1021K mutation was identified in 6 patients, and a splice site mutation in one.
Conclusions:
- The p.E1021K mutation is the most frequent genetic alteration in pediatric APDS.
- Suspicion of APDS is warranted in children with recurrent infections, hepatosplenomegaly, lymphadenopathy, otitis media, or caries, especially with bronchoscopic findings of nodular protrusions.
Objectives:
To summarize the clinical data of 7 children with activated phosphoinositide 3-kinase delta syndrome (APDS) and enhance understanding of the disease.
Methods:
A retrospective analysis was conducted on clinical data of 7 APDS children admitted to Hunan Provincial People's Hospital from January 2019 to August 2023.
Results:
Among the 7 children (4 males, 3 females), the median age of onset was 30 months, and the median age at diagnosis was 101 months. Recurrent respiratory tract infections, hepatosplenomegaly, and multiple lymphadenopathy were observed in all 7 cases. Sepsis was observed in 5 cases, otitis media and multiple caries were observed in 3 cases, and diarrhea and joint pain were observed in 2 cases. Lymphoma and systemic lupus erythematosus were observed in 1 case each. Fiberoptic bronchoscopy was performed in 4 cases, revealing scattered nodular protrusions in the bronchial lumen. The most common respiratory pathogen was Streptococcus pneumoniae (4 cases). Six patients had a p.E1021K missense mutation, and one had a p.434-475del splice site mutation.
Conclusions:
p.E1021K is the most common mutation site in APDS children. Children who present with one or more of the following symptoms: recurrent respiratory tract infections, hepatosplenomegaly, multiple lymphadenopathy, otitis media, and caries, and exhibit scattered nodular protrusions on fiberoptic bronchoscopy, should be vigilant for APDS. Citation:Chinese Journal of Contemporary Pediatrics, 2024, 26(5): 499-505.
More Related Videos
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
IP3/DAG Signaling Pathway

